XB-ART-46757Mol Pharm. April 1, 2013; 10 (4): 1450-8.
Polyamines are ubiquitous organic cations implicated in many physiological processes. Because they are positively charged at physiological pH, carrier-mediated systems are necessary for effective membrane permeation, but the identity of specific polyamine transporter proteins in eukaryotic cells remains unclear. Polyspecific organic cation transporters (OCTs) interact with many natural and xenobiotic monovalent cations and have been reported to transport dicationic compounds, including the short polyamine putrescine. In this study, we used Xenopus oocytes expressing mammalian OCT1 (SLC22A1), OCT2 (SLC22A2), or OCT3 (SLC22A3) to assess binding and transport of longer-chain polyvalent polyamines. In OCT-expressing oocytes, [(3)H]MPP(+) uptake rates were 15- to 35-fold higher than in noninjected oocytes, whereas those for [(3)H]spermidine increased more modestly above the background, up to 3-fold. This reflected up to 20-fold lower affinity for spermidine than for MPP(+); thus, K(0.5) for MPP(+) was ~50 μM in OCT1, ~170 μM in OCT2, and ~60 μM in OCT3, whereas for spermidine, K(0.5) was ~1 mM in OCT1, OCT2, and OCT3. J(max) values for MPP(+) and spermidine were within the same range, suggesting that both compounds are transported at a similar turnover rate. To gain further insight into OCT substrate specificity, we screened a selection of structural polyamine analogues for effect on [(3)H]MPP(+) uptake. In general, blocking potency increased with overall hydrophobic character, which indicates that, as for monovalent cations, hydrophobicity is a major requirement for recognition in polyvalent OCT substrates and inhibitors. Our results demonstrate that the natural polyamines are low affinity, but relatively high turnover, substrates for OCTs. The identification of OCTs as polyamine transport systems may contribute to further understanding of the mechanisms involved in polyamine homeostasis and aid in the design of polyamine-like OCT-targeted drugs.
PubMed ID: 23458604
PMC ID: PMC3632321
Article link: Mol Pharm.
Grant support: G12 MD007583 NIMHD NIH HHS, G12 RR003035 NCRR NIH HHS , HL54171 NHLBI NIH HHS , HL54171 NHLBI NIH HHS , HL54171 NHLBI NIH HHS , HL54171 NHLBI NIH HHS , HL54171 NHLBI NIH HHS , HL54171 NHLBI NIH HHS , NS065201 NINDS NIH HHS , R01 HL054171 NHLBI NIH HHS , R01 HL054171 NHLBI NIH HHS , R01 HL054171 NHLBI NIH HHS , R01 HL054171 NHLBI NIH HHS , R01 HL054171 NHLBI NIH HHS , R01 HL054171 NHLBI NIH HHS , R01 NS065201 NINDS NIH HHS
Genes referenced: pou2f1 pou2f2 slc22a2